CP intervention failed to improve NAFLD-related parameters in Pparα−/− mice such as body weight, epididymal adipose weight, liver TG, hepatic steatosis score (Fig. 7A–D). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.